Evidence map›Paper›PMID 21855411›Full record

ReviewTrends in immunology2011

Enhancer-promoter communication and transcriptional regulation of Igh.

Ananda L Roy, Ranjan Sen, Robert G Roeder

Open access · greenAbstract readReview
In one paragraph

Review in Trends in immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Molecular characterization of the genome-wideFrontiers in plant science · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Haematologica · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Ananda L RoyProgram in Immunology, Department of Pathology, Tufts University School of Medicine, Boston, MA, USA. ananda.roy@tufts.edu
Ranjan Sen
Robert G Roeder
MRC Laboratory of Molecular Biology · GBRockefeller University · USTufts University · US

Funding

Activation and inactivation of VH gene recombinationZIAAG000372 · NIA · NATIONAL INSTITUTE ON AGING · PI SEN, RANJAN · 2009 to 2021
$4.9M
Role of OCA-B in B cell differentiation and malignancyR01CA113872 · NCI · ROCKEFELLER UNIVERSITY · PI ROEDER, ROBERT G · 2005 to 2009
$2.6M
Role of TFII-I in B cell functionR56AI079206 · NIAID · TUFTS UNIVERSITY BOSTON · PI ROY, ANANDA L · 2010 to 2010
$396k
Intramural NIH HHSNCI NIH HHS CA113872NCI NIH HHS R01 CA113872NIAID NIH HHS 1R56AI079206NIAID NIH HHS R56 AI079206
6 · The paper itself

Abstract

Transcriptional regulation of eukaryotic protein-coding genes requires the participation of site-specific transcription factors that bind distal regulatory elements, as well as factors that, together with RNA polymerase II, form the basal transcription machinery at the core promoter. Gene regulation requires proper communication between promoters and enhancers, often over great distances. Therefore, it is important to understand the potentially inter-related transcription factor interactions at both of these elements. How this is achieved on tissue-specific genes, such as the immunoglobulin heavy chain (IgH) in B cells remains unclear. Here, we review known interactions at the Igh variable region (V(H)) promoters and present our perspective on promoter-enhancer interactions that are likely important for Ig gene regulation in B cells.

Indexed as

Enhancer Elements, GeneticGene Expression RegulationPromoter Regions, GeneticAnimalsB-LymphocytesHumansImmunoglobulin Heavy ChainsTranscription, GeneticImmunoglobulin Heavy Chains

Identifiers

PMID21855411
PMCPMC3200469
OpenAlexW2034917743

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.